BlackBarn Capital Partners LP In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), BlackBarn Capital Partners LP reported 17 stock positions worth $194.0 million . Its top holding was Roivant Sciences (ROIV) at 16.9% of the portfolio, followed by Unitedhealth (UNH, 8.4% ) and Molina Healthcare (MOH, 8.0% ). Compared with Q1 2024, it opened 2 new positions, sold out of 6, added to 8 and reduced 1. The biggest buy was a new position in Blue Ridge Bankshares (BRBS) and the biggest sale an exit from CF Industries (CF).
Location NEW YORK, NY
CIK 0002010204
Portfolio Value $194.0M (Q2 2024) Holdings 17 stocks · $194.0M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 ROIV Roivant Sciences Ltd. 16.89% 3,100,000 $32.8M Add +63.1% UNH Unitedhealth Group Inc. 8.40% 32,000 $16.3M Add +6.7% MOH Molina Healthcare Inc. 8.05% 52,500 $15.6M Add +25.3% AMRX Amneal Pharmaceuticals Inc. 6.55% 2,000,000 $12.7M Add +41.5% BRBS Blue Ridge Bankshares Inc. 6.33% 4,702,747 $12.3M New DHC Diversified Healthcare Trust 6.29% 4,000,000 $12.2M Add +128.6% T AT&T Inc. 5.91% 600,000 $11.5M New CHRD Chord Energy Corp. 5.53% 64,000 $10.7M Reduce -21.9% RH RH 5.50% 43,655 $10.7M Add +156.8% ELV Elevance Health Inc. 5.03% 18,000 $9.8M No change CIVI Civitas Resources Inc. 4.98% 140,000 $9.7M No change KNF Knife River Corp. 4.88% 135,000 $9.5M No change TEVA Teva Pharmaceutical-SP ADR 4.19% 500,000 $8.1M No change PRVA Privia Health Group Inc. 3.58% 400,000 $7.0M Add +100.0% ABUS Arbutus Biopharma Corp. 3.30% 2,070,900 $6.4M No change BVFL BV Financial Inc. filed as BV FINL INC 2.95% 480,000 $5.7M No change TCBX Third Coast Bancshares Inc. 1.64% 150,000 $3.2M Add +14.7%
Options reported separately and not counted above: QQQ puts ($598.9M), NVDA puts ($210.0M), COIN puts ($111.1M), ODD puts ($11.1M).
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ CF CF Industries Holdings Inc. Sold out 0.00% −7.22 GPK Graphic Packaging Holding Co. Sold out 0.00% −6.75 IBKR Interactive Brokers Gro Class A Sold out 0.00% −3.88 CHRD Chord Energy Corp. Reduce -21.9% 5.53% −2.92 ADV Advantage Solutions Inc. Sold out 0.00% −0.53 OPTU Optimum Communications Inc. Class A Sold out 0.00% −0.38 FRBA First Bank/Hamilton NJ Sold out 0.00% −0.15
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ BRBS Blue Ridge Bankshares Inc. New 6.33% +6.33 T AT&T Inc. New 5.91% +5.91 ROIV Roivant Sciences Ltd. Add +63.1% 16.89% +5.31 DHC Diversified Healthcare Trust Add +128.6% 6.29% +3.80 RH RH Add +156.8% 5.50% +2.08 AMRX Amneal Pharmaceuticals Inc. Add +41.5% 6.55% +1.60 PRVA Privia Health Group Inc. Add +100.0% 3.58% +1.32 TCBX Third Coast Bancshares Inc. Add +14.7% 1.64% +0.13 UNH Unitedhealth Group Inc. Add +6.7% 8.40% −0.18 MOH Molina Healthcare Inc. Add +25.3% 8.05% −1.91
Options Activity Q1 2024 → Q2 2024 Security Type Change vs Q1 2024 Underlying Shares Value ▼ QQQ Invesco QQQ Trust Series 1 put Add +41566.7% 1,250,000 $598.9M NVDA Nvidia Corp. put New 1,700,000 $210.0M COIN Coinbase Global Inc. Class A put New 500,000 $111.1M ODD Oddity Tech Ltd. Class A put New 282,700 $11.1M SPY SS SPDR S&P 500 ETF Trust-US put Sold out 5,000 $2.6Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 17 $402.2M ROIV, PRVA, DHC, NEE, NIQ Q1 2026 14 $332.4M ROIV, VECO, PRVA, DHC, NEE Q4 2025 11 $278.9M ROIV, DHC, PRVA, NIQ, NEE Q3 2025 15 $306.4M ROIV, PRVA, DHC, NXT, AMRX Q2 2025 20 $301.8M ROIV, AMRX, ACLS, DHC, MOH Q1 2025 18 $292.8M ROIV, UNH, MOH, AMRX, ACLS Q4 2024 15 $254.1M ROIV, UNH, MOH, TEVA, AMRX Q3 2024 18 $230.1M ROIV, MOH, AMRX, DHC, T Q2 2024 17 $194.0M ROIV, UNH, MOH, AMRX, BRBS Q1 2024 21 $173.0M ROIV, MOH, UNH, CHRD, CF